A detailed history of Eisler Capital (Us) LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Eisler Capital (Us) LLC holds 11,782 shares of ABT stock, worth $1.36 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,782
Previous 15,996 26.34%
Holding current value
$1.36 Million
Previous $1.66 Billion 19.18%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $421,694 - $497,799
-4,214 Reduced 26.34%
11,782 $1.34 Billion
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $825,583 - $921,558
8,196 Added 105.08%
15,996 $1.66 Billion
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $854,256 - $943,488
7,800 New
7,800 $887 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $2.68 Million - $3.22 Million
28,097 New
28,097 $2.72 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Eisler Capital (Us) LLC Portfolio

Follow Eisler Capital (Us) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eisler Capital (Us) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eisler Capital (Us) LLC with notifications on news.